CIK 0001404644
- Non-accelerated filer
- Smaller reporting company
Neurogene Inc.
Sign in to watch- Ticker
- NGNE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 980542593
- Phone
- +1 877-237-5020
- Business address
- 535 W 24TH STREET, 5TH FLOOR, NEW YORK, NY, 10011
- Former names
- Neoleukin Therapeutics, Inc., AQUINOX PHARMACEUTICALS, INC, AQUINOX PHARMACEUTICALS (USA) INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Senior Vice President sold 600 shares at $10.19 ($6,114)
- 4 Open-market sale Senior Vice President sold 650 shares at $10.82 ($7,036)
- 4 Open-market sale Senior Vice President sold 600 shares at $11.00 ($6,600)
- 4 Open-market sale Senior Vice President sold 600 shares at $10.00 ($6,000)
- 4 Open-market buy President and CEO bought 50,000 shares at an average $9.51 ($475,354)
- 4 Open-market sale Senior Vice President sold 600 shares at $10.00 ($6,000)
- 4 Open-market sale Senior Vice President sold 600 shares at $10.63 ($6,378)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Senior Vice President sold 1,200 shares at $11.09 ($13,308)
- 4 Open-market sale Senior Vice President sold 1,200 shares at $11.30 ($13,560)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 6 of 15 · 287 filings